Molecular Imaging-guided Precise Theranostics
WANG Guochang, ZHU Zhaohui
2022, 13(2): 165-168. DOI: 10.12290/xhyxzz.2021-0773
Abstract FullText HTML PDF
Finding Possible Solutions for the Management of Systemic Lupus Erythematosus from the Current Situation and Challenges in China
TIAN Xinping, LI Mengtao, ZENG Xiaofeng
2022, 13(2): 169-173. DOI: 10.12290/xhyxzz.2022-0020
Abstract FullText HTML PDF
How to Implement Personalized Therapy According to Clinical Guidelines: From International Guidelines for Management of Sepsis and Septic Shock
ZHAO Hua, LIU Dawei
2022, 13(2): 174-179. DOI: 10.12290/xhyxzz.2021-0811
Abstract FullText HTML PDF
Clinical Translational Research of Evans Blue Modified Peptides Used for Theranostics
LIU Qingxing, CHEN Xiaoyuan, ZHU Zhaohui
2022, 13(2): 180-186. DOI: 10.12290/xhyxzz.2021-0764
Abstract FullText HTML PDF
Development and Prospect of Theranostic Medical Isotopes and Radiopharmaceuticals in China
2022, 13(2): 187-191. DOI: 10.12290/xhyxzz.2021-0557
Abstract FullText HTML PDF
Prostate Specific Membrane Antigen PET/MRI for the Management of Prostate Cancer: Current Status and Future Directions
LI Hui, YANG Zhi
2022, 13(2): 192-198. DOI: 10.12290/xhyxzz.2021-0492
Abstract FullText HTML PDF
Treatment of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms by Radionuclide Therapy: Practice and Experience
LEI Lei, DU Tao, OU Xia, ZHU Yan, ZHANG Yu, ZHANG Wei
2022, 13(2): 199-202. DOI: 10.12290/xhyxzz.2021-0715
Abstract FullText HTML PDF
Chinese Guidelines for Diagnosis and Treatment of Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome(2021 edition)
Acquired Immunodeficiency Syndrome and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association, Chinese Center for Disease Control and Prevention
2022, 13(2): 203-226. DOI: 10.12290/xhyxzz.2022-0097
Abstract FullText HTML PDF
Expert Consensus on Clinical Application of Integrin RGD Receptor Imaging (2022)
Chinese Society of Nuclear Medicine, Chinese Society of Molecular Imaging in Chinese Biophysical Society
2022, 13(2): 227-234. DOI: 10.12290/xhyxzz.2022-0089
Abstract FullText HTML PDF
Expert Consensus on the Application of Multi-criteria Decision Analysis in Clinical Comprehensive Evaluation of Orphan Drugs(2022)
Multi-disciplinary Team for Rare Diseases, Peking Union Medical College Hospital, National Rare Diseases Committee
2022, 13(2): 235-254. DOI: 10.12290/xhyxzz.2022-0013
Abstract FullText HTML PDF
Interpretation of the Chinese Guidelines on Medical Nutritional Therapy for Overweight/Obesity(2021)
SUN Mingyao, CHEN Wei
2022, 13(2): 255-262. DOI: 10.12290/xhyxzz.2021-0796
Abstract FullText HTML PDF
Comparative Study of 18F-FDG PET/CT Metabolic Alteration Patterns in Cerebral Amyloid Angiopathy and Alzheimer's Disease
JIA Chenhao, WU Meiqi, GUO Ruijie, NI Jun, CUI Ruixue
2022, 13(2): 263-269. DOI: 10.12290/xhyxzz.2021-0693
Abstract FullText HTML PDF
Analysis of the Features of 18F-FDG PET/CT and Enhanced CT in Patients with Primary Pulmonary Mucinous Adenocarcinoma
HAN Pingping, FU Liping, ZHANG Ling, FENG Hongxiang, SHI Yanfen, ZHENG Yumin
2022, 13(2): 270-276. DOI: 10.12290/xhyxzz.2021-0705
Abstract FullText HTML PDF
Analysis of Clinical Manifestations and Drug Therapies of Gitelman Syndrome
ZHAO Zhe, TANG Yan, ZHOU Jingya, CHEN Xiaoguang, ZHANG Lei, CHEN Limeng, YUAN Tao
2022, 13(2): 277-286. DOI: 10.12290/xhyxzz.2021-0180
Abstract FullText HTML PDF
Advances in Dynamic Monitoring of Immune Checkpoint Inhibitors as the Prognostic Markers for Advanced Non-small Cell Lung Cancer
DAI Liyuan, SHI Yuankai, HAN Xiaohong
2022, 13(2): 287-295. DOI: 10.12290/xhyxzz.2021-0608
Abstract FullText HTML PDF
Progress of NLRP3 Inflammasome and Myocardial Ischemia Reperfusion Injury
ZHANG Xi, HUANG Bing, WANG Guipeng
2022, 13(2): 296-301. DOI: 10.12290/xhyxzz.2021-0619
Abstract FullText HTML PDF
Progress in the Application of Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation and Chronic Renal Insufficiency
LI Xin, LIU Lu, LIU Zhihong, ZHAO Zhihui, LUO Qin, ZHAO Qing
2022, 13(2): 302-307. DOI: 10.12290/xhyxzz.2021-0256
Abstract FullText HTML PDF
Risk Factors and Pathogenesis of the Recurrence of Psoriasis
LIU Xiaohan, JIN Hongzhong
2022, 13(2): 308-314. DOI: 10.12290/xhyxzz.2021-0367
Abstract FullText HTML PDF
Research Progress of Breast Ultrasound in the Screening of Breast Cancer
WANG Yingjiao, WANG Lihong, LI Ruyin, SHEN Songjie, SUN Qiang
2022, 13(2): 315-319. DOI: 10.12290/xhyxzz.2021-0462
Abstract FullText HTML PDF
Aggravated Primary Lymphedema of Contralateral Upper Limb After the Radical Mastectomy: A Case Report
LIU Ying, PAN Weiren, GUAN Jinghong, ZHAO Wowa, LONG Xiao
2022, 13(2): 320-323. DOI: 10.12290/xhyxzz.2021-0408
Abstract FullText HTML PDF
Investigation and Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019:Methodological and Reporting Quality
LIU Yunlan, ZHANG Jingyi, SHI Qianling, YANG Nan, WANG Zijun, LUO Xufei, REN Mengjuan, XUN Yangqin, ZHOU Qi, LIU Hui, LYU Meng, CHEN Yaolong
2022, 13(2): 324-331. DOI: 10.12290/xhyxzz.2022-0027
Abstract FullText HTML PDF
Polymorphism of Gut Microbiota in High Altitude Tibetan Patients with Coronary Artery Heart Disease
GAO Zhongshan, REN Ming, MA Yulan, ZHU Lulu
2022, 13(2): 332-340. DOI: 10.12290/xhyxzz.2021-0652
Abstract FullText HTML PDF
Novel Treatment Strategies for Advanced Pancreatic Ductal Adenocarcinoma
CHENG Yuejuan, GUAN Mei, WANG Xiang, BAI Chunmei
2022, 13(2): 341-348. DOI: 10.12290/xhyxzz.2021-0139
Abstract FullText HTML PDF
Case-based Sandwich Teaching Improves Communication Confidence of Eight-year Undergraduates: Treatment of Breast Cancer
PAN Bo, ZHOU Yidong, YAO Ru, ZHAO Jun, JIANG Yingzi, LUO Linzhi, PAN Hui
2022, 13(2): 349-352. DOI: 10.12290/xhyxzz.2021-0749
Abstract FullText HTML PDF